{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T08:53:31Z","timestamp":1782550411021,"version":"3.54.5"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,4,5]],"date-time":"2014-04-05T00:00:00Z","timestamp":1396656000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s12035-014-8688-7","type":"journal-article","created":{"date-parts":[[2014,4,4]],"date-time":"2014-04-04T10:20:19Z","timestamp":1396606819000},"page":"1131-1141","source":"Crossref","is-referenced-by-count":3,"title":["Sustained Increase of PKA Activity in the Postcommissural Putamen of Dyskinetic Monkeys"],"prefix":"10.1007","volume":"50","author":[{"given":"Garikoitz","family":"Azkona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Marcilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakel","family":"L\u00f3pez de Maturana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaya","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"P\u00e9rez-Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Rosario","family":"Luquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Sanchez-Pernaute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,5]]},"reference":[{"key":"8688_CR1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/mds.870070204","volume":"7","author":"MR Luquin","year":"1992","unstructured":"Luquin MR, Scipioni O, Vaamonde J, Gershanik O, Obeso JA (1992) Levodopa-induced dyskinesias in Parkinson\u2019s disease: clinical and pharmacological classification. Mov Disord 7:117\u2013124","journal-title":"Mov Disord"},{"key":"8688_CR2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1124\/pr.111.005678","volume":"65","author":"P Huot","year":"2013","unstructured":"Huot P, Johnston TH, Koprich JB, Fox SH, Brotchie JM (2013) The pharmacology of l-DOPA-induced dyskinesia in Parkinson\u2019s disease. Pharmacol Rev 65:171\u2013222","journal-title":"Pharmacol Rev"},{"key":"8688_CR3","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1468-1331.2005.01096.x","volume":"12","author":"M Pechevis","year":"2005","unstructured":"Pechevis M, Clarke CE, Vieregge P, Khoshnood B, Deschaseaux-Voinet C, Berdeaux G, Ziegler M (2005) Effects of dyskinesias in Parkinson\u2019s disease on quality of life and health-related costs: a prospective European study. Eur J Neurol 12:956\u2013963","journal-title":"Eur J Neurol"},{"key":"8688_CR4","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1136\/jnnp.2009.173286","volume":"81","author":"SW Hung","year":"2010","unstructured":"Hung SW, Adeli GM, Arenovich T, Fox SH, Lang AE (2010) Patient perception of dyskinesia in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 81:1112\u20131115","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8688_CR5","first-page":"1605","volume":"9","author":"P Bargiotas","year":"2013","unstructured":"Bargiotas P, Konitsiotis S (2013) Levodopa-induced dyskinesias in Parkinson\u2019s disease: emerging treatments. Neuropsychiatr Dis Treat 9:1605\u20131617","journal-title":"Neuropsychiatr Dis Treat"},{"key":"8688_CR6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fnana.2011.00051","volume":"5","author":"MG Murer","year":"2011","unstructured":"Murer MG, Moratalla R (2011) Striatal signaling in l-DOPA-induced dyskinesia: common mechanisms with drug abuse and long term memory involving D1 dopamine receptor stimulation. Front Neuroanat 5:51","journal-title":"Front Neuroanat"},{"key":"8688_CR7","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nn1040","volume":"6","author":"B Picconi","year":"2003","unstructured":"Picconi B, Centonze D, Hakansson K, Bernardi G, Greengard P, Fisone G, Cenci MA, Calabresi P (2003) Loss of bidirectional striatal synaptic plasticity in l-DOPA-induced dyskinesia. Nat Neurosci 6:501\u2013506","journal-title":"Nat Neurosci"},{"key":"8688_CR8","doi-asserted-by":"crossref","first-page":"6995","DOI":"10.1523\/JNEUROSCI.0852-07.2007","volume":"27","author":"E Santini","year":"2007","unstructured":"Santini E, Valjent E, Usiello A, Carta M, Borgkvist A, Girault JA, Herve D, Greengard P, Fisone G (2007) Critical involvement of cAMP\/DARPP-32 and extracellular signal-regulated protein kinase signaling in l-DOPA-induced dyskinesia. J Neurosci 27:6995\u20137005","journal-title":"J Neurosci"},{"key":"8688_CR9","doi-asserted-by":"crossref","first-page":"e42652","DOI":"10.1371\/journal.pone.0042652","volume":"7","author":"A Aristieta","year":"2012","unstructured":"Aristieta A, Azkona G, Sagarduy A, Miguelez C, Ruiz-Ortega JA, Sanchez-Pernaute R, Ugedo L (2012) The role of the subthalamic nucleus in l-DOPA induced dyskinesia in 6-hydroxydopamine lesioned rats. PLoS One 7:e42652","journal-title":"PLoS One"},{"key":"8688_CR10","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.neuropharm.2013.11.024","volume":"79","author":"G Azkona","year":"2014","unstructured":"Azkona G, Sagarduy A, Aristieta A, Vazquez N, Zubillaga V, Ruiz-Ortega JA, Perez-Navarro E, Ugedo L, Sanchez-Pernaute R (2014) Buspirone anti-dyskinetic effect is correlated with temporal normalization of dysregulated striatal DRD1 signalling in l-DOPA-treated rats. Neuropharmacology 79:726\u2013737","journal-title":"Neuropharmacology"},{"key":"8688_CR11","doi-asserted-by":"crossref","first-page":"7113","DOI":"10.1523\/JNEUROSCI.3952-07.2008","volume":"28","author":"CR Gerfen","year":"2008","unstructured":"Gerfen CR, Paletzki R, Worley P (2008) Differences between dorsal and ventral striatum in Drd1a dopamine receptor coupling of dopamine- and cAMP-regulated phosphoprotein-32 to activation of extracellular signal-regulated kinase. J Neurosci 28:7113\u20137120","journal-title":"J Neurosci"},{"key":"8688_CR12","doi-asserted-by":"crossref","first-page":"e12322","DOI":"10.1371\/journal.pone.0012322","volume":"5","author":"E Santini","year":"2010","unstructured":"Santini E, Sgambato-Faure V, Li Q, Savasta M, Dovero S, Fisone G, Bezard E (2010) Distinct changes in cAMP and extracellular signal-regulated protein kinase signalling in l-DOPA-induced dyskinesia. PLoS One 5:e12322","journal-title":"PLoS One"},{"key":"8688_CR13","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.neures.2011.12.006","volume":"72","author":"A Martinez","year":"2012","unstructured":"Martinez A, Macheda T, Morgese MG, Trabace L, Giuffrida A (2012) The cannabinoid agonist WIN55212-2 decreases l-DOPA-induced PKA activation and dyskinetic behavior in 6-OHDA-treated rats. Neurosci Res 72:236\u2013242","journal-title":"Neurosci Res"},{"key":"8688_CR14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(97)00355-8","volume":"228","author":"JD Oh","year":"1997","unstructured":"Oh JD, Del Dotto P, Chase TN (1997) Protein kinase A inhibitor attenuates levodopa-induced motor response alterations in the hemi-parkinsonian rat. Neurosci Lett 228:5\u20138","journal-title":"Neurosci Lett"},{"key":"8688_CR15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.nbd.2009.12.027","volume":"38","author":"M Lebel","year":"2010","unstructured":"Lebel M, Chagniel L, Bureau G, Cyr M (2010) Striatal inhibition of PKA prevents levodopa-induced behavioural and molecular changes in the hemiparkinsonian rat. Neurobiol Dis 38:59\u201367","journal-title":"Neurobiol Dis"},{"key":"8688_CR16","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1523\/JNEUROSCI.5074-06.2007","volume":"27","author":"JM Beaulieu","year":"2007","unstructured":"Beaulieu JM, Tirotta E, Sotnikova TD, Masri B, Salahpour A, Gainetdinov RR, Borrelli E, Caron MG (2007) Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo. J Neurosci 27:881\u2013885","journal-title":"J Neurosci"},{"key":"8688_CR17","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1471-4159.2007.04586.x","volume":"102","author":"E Bychkov","year":"2007","unstructured":"Bychkov E, Ahmed MR, Dalby KN, Gurevich EV (2007) Dopamine depletion and subsequent treatment with l-DOPA, but not the long-lived dopamine agonist pergolide, enhances activity of the Akt pathway in the rat striatum. J Neurochem 102:699\u2013711","journal-title":"J Neurochem"},{"key":"8688_CR18","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.pnpbp.2009.12.011","volume":"34","author":"M Morissette","year":"2010","unstructured":"Morissette M, Samadi P, Hadj Tahar A, Belanger N, Di Paolo T (2010) Striatal Akt\/GSK3 signaling pathway in the development of l-Dopa-induced dyskinesias in MPTP monkeys. Prog Neuropsychopharmacol Biol Psychiatry 34:446\u2013454","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"8688_CR19","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1046\/j.1460-9568.1998.00264.x","volume":"10","author":"M Morissette","year":"1998","unstructured":"Morissette M, Goulet M, Grondin R, Blanchet P, Bedard PJ, Di Paolo T, Levesque D (1998) Associative and limbic regions of monkey striatum express high levels of dopamine D3 receptors: effects of MPTP and dopamine agonist replacement therapies. Eur J Neurosci 10:2565\u20132573","journal-title":"Eur J Neurosci"},{"key":"8688_CR20","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1073\/pnas.94.7.3363","volume":"94","author":"R Bordet","year":"1997","unstructured":"Bordet R, Ridray S, Carboni S, Diaz J, Sokoloff P, Schwartz JC (1997) Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa. Proc Natl Acad Sci U S A 94:3363\u20133367","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8688_CR21","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nm875","volume":"9","author":"E Bezard","year":"2003","unstructured":"Bezard E, Ferry S, Mach U, Stark H, Leriche L, Boraud T, Gross C, Sokoloff P (2003) Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function. Nat Med 9:762\u2013767","journal-title":"Nat Med"},{"key":"8688_CR22","doi-asserted-by":"crossref","first-page":"26016","DOI":"10.1074\/jbc.M710349200","volume":"283","author":"D Marcellino","year":"2008","unstructured":"Marcellino D, Ferre S, Casado V, Cortes A, Le Foll B, Mazzola C, Drago F, Saur O, Stark H, Soriano A, Barnes C, Goldberg SR, Lluis C, Fuxe K, Franco R (2008) Identification of dopamine D1\u2013D3 receptor heteromers: indications for a role of synergistic D1\u2013D3 receptor interactions in the striatum. J Biol Chem 283:26016\u201326025","journal-title":"J Biol Chem"},{"key":"8688_CR23","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/mds.23696","volume":"26","author":"E Bezard","year":"2011","unstructured":"Bezard E, Przedborski S (2011) A tale on animal models of Parkinson\u2019s disease. Mov Disord 26:993\u20131002","journal-title":"Mov Disord"},{"key":"8688_CR24","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1093\/brain\/awm061","volume":"130","author":"W San Sebastian","year":"2007","unstructured":"San Sebastian W, Guillen J, Manrique M, Belzunegui S, Ciordia E, Izal-Azcarate A, Garrido-Gil P, Vazquez-Claverie M, Luquin MR (2007) Modification of the number and phenotype of striatal dopaminergic cells by carotid body graft. Brain 130:1306\u20131316","journal-title":"Brain"},{"key":"8688_CR25","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/NEN.0b013e3181b35e41","volume":"68","author":"M Vazquez-Claverie","year":"2009","unstructured":"Vazquez-Claverie M, Garrido-Gil P, San Sebastian W, Izal-Azcarate A, Belzunegui S, Marcilla I, Lopez B, Luquin MR (2009) Acute and chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administrations elicit similar microglial activation in the substantia nigra of monkeys. J Neuropathol Exp Neurol 68:977\u2013984","journal-title":"J Neuropathol Exp Neurol"},{"key":"8688_CR26","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0896-6273(00)80733-3","volume":"22","author":"MR Luquin","year":"1999","unstructured":"Luquin MR, Montoro RJ, Guillen J, Saldise L, Insausti R, Del Rio J, Lopez-Barneo J (1999) Recovery of chronic parkinsonian monkeys by autotransplants of carotid body cell aggregates into putamen. Neuron 22:743\u2013750","journal-title":"Neuron"},{"key":"8688_CR27","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.nbd.2007.04.016","volume":"27","author":"R Sanchez-Pernaute","year":"2007","unstructured":"Sanchez-Pernaute R, Jenkins BG, Choi JK, Iris Chen YC, Isacson O (2007) In vivo evidence of D3 dopamine receptor sensitization in parkinsonian primates and rodents with l-DOPA-induced dyskinesias. Neurobiol Dis 27:220\u2013227","journal-title":"Neurobiol Dis"},{"key":"8688_CR28","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1007\/s00726-010-0662-8","volume":"39","author":"G Azkona","year":"2010","unstructured":"Azkona G, Levannon D, Groner Y, Dierssen M (2010) In vivo effects of APP are not exacerbated by BACE2 co-overexpression: behavioural characterization of a double transgenic mouse model. Amino Acids 39:1571\u20131580","journal-title":"Amino Acids"},{"key":"8688_CR29","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.brainres.2008.02.009","volume":"1207","author":"L Xiang","year":"2008","unstructured":"Xiang L, Szebeni K, Szebeni A, Klimek V, Stockmeier CA, Karolewicz B, Kalbfleisch J, Ordway GA (2008) Dopamine receptor gene expression in human amygdaloid nuclei: elevated D4 receptor mRNA in major depression. Brain Res 1207:214\u2013224","journal-title":"Brain Res"},{"key":"8688_CR30","author":"LF Potts","year":"2013","unstructured":"Potts LF, Wu H, Singh A, Marcilla I, Luquin MR, Papa SM (2013) Modeling Parkinson\u2019s disease in monkeys for translational studies, a critical analysis. Exp Neurol. doi: 10.1016\/j.expneurol.2013.09.014","journal-title":"Exp Neurol"},{"issue":"6","key":"8688_CR31","doi-asserted-by":"crossref","first-page":"e66377","DOI":"10.1371\/journal.pone.0066377","volume":"8","author":"C Ordonez","year":"2013","unstructured":"Ordonez C, Moreno-Murciano P, Hernandez M, Di Caudo C, Carril-Mundinano I, Vazquez N, Sanchez-Pernaute R, Luquin MR (2013) Sox-2 positive neural progenitors in the primate striatum undergo dynamic changes after dopamine denervation. PLoS One 8(6):e66377","journal-title":"PLoS One"},{"key":"8688_CR32","doi-asserted-by":"crossref","first-page":"9849","DOI":"10.1073\/pnas.95.17.9849","volume":"95","author":"X Cheng","year":"1998","unstructured":"Cheng X, Ma Y, Moore M, Hemmings BA, Taylor SS (1998) Phosphorylation and activation of cAMP-dependent protein kinase by phosphoinositide-dependent protein kinase. Proc Natl Acad Sci U S A 95:9849\u20139854","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8688_CR33","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/347146a0","volume":"347","author":"P Sokoloff","year":"1990","unstructured":"Sokoloff P, Giros B, Martres MP, Bouthenet ML, Schwartz JC (1990) Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347:146\u2013151","journal-title":"Nature"},{"key":"8688_CR34","doi-asserted-by":"crossref","first-page":"8155","DOI":"10.1073\/pnas.89.17.8155","volume":"89","author":"D Levesque","year":"1992","unstructured":"Levesque D, Diaz J, Pilon C, Martres MP, Giros B, Souil E, Schott D, Morgat JL, Schwartz JC, Sokoloff P (1992) Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin. Proc Natl Acad Sci U S A 89:8155\u20138159","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8688_CR35","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/sj.npp.1300182","volume":"28","author":"NM Richtand","year":"2003","unstructured":"Richtand NM, Welge JA, Levant B, Logue AD, Hayes S, Pritchard LM, Geracioti TD, Coolen LM, Berger SP (2003) Altered behavioral response to dopamine D3 receptor agonists 7-OH-DPAT and PD 128907 following repetitive amphetamine administration. Neuropsychopharmacology 28:1422\u20131432","journal-title":"Neuropsychopharmacology"},{"key":"8688_CR36","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0306-4522(02)00548-1","volume":"116","author":"JM Kampen van","year":"2003","unstructured":"van Kampen JM, Stoessl AJ (2003) Effects of oligonucleotide antisense to dopamine D3 receptor mRNA in a rodent model of behavioural sensitization to levodopa. Neuroscience 116:307\u2013314","journal-title":"Neuroscience"},{"key":"8688_CR37","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0022-3565(24)37098-3","volume":"283","author":"PJ Blanchet","year":"1997","unstructured":"Blanchet PJ, Konitsiotis S, Chase TN (1997) Motor response to a dopamine D3 receptor preferring agonist compared to apomorphine in levodopa-primed 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys. J Pharmacol Exp Ther 283:794\u2013799","journal-title":"J Pharmacol Exp Ther"},{"key":"8688_CR38","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.neuropharm.2009.01.020","volume":"56","author":"R Kumar","year":"2009","unstructured":"Kumar R, Riddle L, Griffin SA, Grundt P, Newman AH, Luedtke RR (2009) Evaluation of the D3 dopamine receptor selective antagonist PG01037 on l-dopa-dependent abnormal involuntary movements in rats. Neuropharmacology 56:944\u2013955","journal-title":"Neuropharmacology"},{"key":"8688_CR39","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.neuropharm.2009.01.019","volume":"56","author":"R Kumar","year":"2009","unstructured":"Kumar R, Riddle LR, Griffin SA, Chu W, Vangveravong S, Neisewander J, Mach RH, Luedtke RR (2009) Evaluation of D2 and D3 dopamine receptor selective compounds on l-dopa-dependent abnormal involuntary movements in rats. Neuropharmacology 56:956\u2013969","journal-title":"Neuropharmacology"},{"key":"8688_CR40","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.1523\/JNEUROSCI.5884-08.2009","volume":"29","author":"A Berthet","year":"2009","unstructured":"Berthet A, Porras G, Doudnikoff E, Stark H, Cador M, Bezard E, Bloch B (2009) Pharmacological analysis demonstrates dramatic alteration of D1 dopamine receptor neuronal distribution in the rat analog of l-DOPA-induced dyskinesia. J Neurosci 29:4829\u20134835","journal-title":"J Neurosci"},{"key":"8688_CR41","doi-asserted-by":"crossref","first-page":"17921","DOI":"10.1523\/JNEUROSCI.2664-12.2012","volume":"32","author":"V Bagetta","year":"2012","unstructured":"Bagetta V, Sgobio C, Pendolino V, Del Papa G, Tozzi A, Ghiglieri V, Giampa C, Zianni E, Gardoni F, Calabresi P, Picconi B (2012) Rebalance of striatal NMDA\/AMPA receptor ratio underlies the reduced emergence of dyskinesia during D2-like dopamine agonist treatment in experimental Parkinson\u2019s disease. J Neurosci 32:17921\u201317931","journal-title":"J Neurosci"},{"key":"8688_CR42","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.biopsych.2005.05.044","volume":"59","author":"N Pavon","year":"2006","unstructured":"Pavon N, Martin AB, Mendialdua A, Moratalla R (2006) ERK phosphorylation and FosB expression are associated with l-DOPA-induced dyskinesia in hemiparkinsonian mice. Biol Psychiatry 59:64\u201374","journal-title":"Biol Psychiatry"},{"key":"8688_CR43","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.biopsych.2006.11.032","volume":"62","author":"JE Westin","year":"2007","unstructured":"Westin JE, Vercammen L, Strome EM, Konradi C, Cenci MA (2007) Spatiotemporal pattern of striatal ERK1\/2 phosphorylation in a rat model of l-DOPA-induced dyskinesia and the role of dopamine D1 receptors. Biol Psychiatry 62:800\u2013810","journal-title":"Biol Psychiatry"},{"key":"8688_CR44","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.biopsych.2009.04.025","volume":"66","author":"S Darmopil","year":"2009","unstructured":"Darmopil S, Martin AB, De Diego IR, Ares S, Moratalla R (2009) Genetic inactivation of dopamine D1 but not D2 receptors inhibits l-DOPA-induced dyskinesia and histone activation. Biol Psychiatry 66:603\u2013613","journal-title":"Biol Psychiatry"},{"key":"8688_CR45","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.brainres.2013.09.020","volume":"1537","author":"D Lindenbach","year":"2013","unstructured":"Lindenbach D, Dupre KB, Eskow Jaunarajs KL, Ostock CY, Goldenberg AA, Bishop C (2013) Effects of 5-HT1A receptor stimulation on striatal and cortical M1 pERK induction by l-DOPA and a D1 receptor agonist in a rat model of Parkinson\u2019s disease. Brain Res 1537:327\u2013339","journal-title":"Brain Res"},{"issue":"Pt 11","key":"8688_CR46","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1093\/brain\/123.11.2297","volume":"123","author":"A Schrag","year":"2000","unstructured":"Schrag A, Quinn N (2000) Dyskinesias and motor fluctuations in Parkinson\u2019s disease. A community-based study. Brain 123(Pt 11):2297\u20132305","journal-title":"Brain"},{"key":"8688_CR47","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.tips.2007.02.006","volume":"28","author":"JM Beaulieu","year":"2007","unstructured":"Beaulieu JM, Gainetdinov RR, Caron MG (2007) The Akt-GSK-3 signaling cascade in the actions of dopamine. Trends Pharmacol Sci 28:166\u2013172","journal-title":"Trends Pharmacol Sci"},{"key":"8688_CR48","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fnmol.2011.00038","volume":"4","author":"JM Beaulieu","year":"2011","unstructured":"Beaulieu JM, Del\u2019guidice T, Sotnikova TD, Lemasson M, Gainetdinov RR (2011) Beyond cAMP: the regulation of Akt and GSK3 by dopamine receptors. Front Mol Neurosci 4:38","journal-title":"Front Mol Neurosci"},{"key":"8688_CR49","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0165-0173(94)00007-C","volume":"20","author":"A Parent","year":"1995","unstructured":"Parent A, Hazrati LN (1995) Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res Brain Res Rev 20:91\u2013127","journal-title":"Brain Res Brain Res Rev"},{"key":"8688_CR50","first-page":"307","volume":"62C","author":"M Bourdenx","year":"2013","unstructured":"Bourdenx M, Nilsson A, Wadensten H, Falth M, Li Q, Crossman AR, Andren PE, Bezard E (2013) Abnormal structure-specific peptide transmission and processing in a primate model of Parkinson\u2019s disease and l-DOPA-induced dyskinesia. Neurobiol Dis 62C:307\u2013312","journal-title":"Neurobiol Dis"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-014-8688-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-014-8688-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-014-8688-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T07:41:30Z","timestamp":1746171690000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-014-8688-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,5]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["8688"],"URL":"https:\/\/doi.org\/10.1007\/s12035-014-8688-7","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,5]]}}}